Brief: Kura Oncology Announces First Patients Dosed In Phase 1 Combination Trial Of Ziftomenib For The Treatment Of Advanced Gist
28/04/2025 13:20
April 28 (Reuters) - Kura Oncology Inc KURA.O: KURA ONCOLOGY ANNOUNCES FIRST PATIENTS DOSED IN PHASE 1 COMBINATION TRIAL OF ZIFTOMENIB FOR THE TREATMENT OF ADVANCED GIST Source text: ID:nGNXc69ZPL Further company coverage: KURA.O ((Reuters.Briefs@thomsonreuters.com;))